Severe Influenza
5
1
1
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
6 treatments under study, led by Xiyanping Injectionoseltamivir Phosphate
Research Leaders
16 sponsors active, led by The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Related Conditions
Often studied with 8 related conditions
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
0.0%
0 terminated out of 5 trials
100.0%
+13.4% vs benchmark
40%
2 trials in Phase 3/4
100%
1 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (5)
Early Corticosteroids in Severe Influenza Pneumonia
Early Oseltamivir Carboxylate Low Plasma Concentration in Patients Admitted to Intensive Care for Severe Influenza
Evaluate the Safety and Efficacy of Xiyanping in Pediatric Participants With Severe Influenza-Like Symptoms
High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza
Randomised, double-blind, multicentre, phase III clinical trial to evaluate the efficacy and safety of dexamethasone compared to placebo in patients with severe influenza (FLUDEX)
Research Network
Common Treatments
- Xiyanping Injectionoseltamivir Phosphate1
- Oseltamivir1
- Dexametasone1
- Absorption Test1
- Oseltamivir Phosphate1
Active Sponsors
- The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine1
- University of Oxford1
- Qingdao Municipal Hospital1
- Assistance Publique - Hôpitaux de Paris1
- Henri Mondor University Hospital1
Top Investigators
Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
CHR Metz-Thionville, Hôpital de Mercy
Assistance Publique Hôpitaux de Paris - CHU Henri Mondor
Queen Sirikit National Institute of Child Health, Bangkok, Thailand
Related Conditions
- Reanimation1
- Infectious Diseases1
- Hygiene1
- Influenza1
- Intensive Care Icu1